Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
On Oct. 16, 2026, EVH is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5184 stocks scored that day.
Evolent Health, Inc. is a small-cap company with a market capitalization of $517M. It ranks number 4 by market capitalization among the 5 Services-Management Services issuers in our coverage with a current forecast.
For EVH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EVH included.
Follow EVH free90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Management Services peers listed below that report each metric.
| Metric | EVH | Rank |
|---|---|---|
| Market Cap | $517M | 4/5 |
| P/B Ratio | 0.60x | – |
| EPS | $-4.88 | – |
| Book Value/Share | $7.60 | – |
| Revenue/Share | $18.55 | – |
| Metric | EVH | Rank |
|---|---|---|
| Gross Margin | 17.2% | – |
| Operating Margin | 18.2% | – |
| EBT Margin | 21.4% | – |
| Tax Rate | -0.6% | – |
| Metric | EVH | Rank |
|---|---|---|
| Current Ratio | 1.24x | 1/6 |
| D/E Ratio | 1.11x | – |
| Interest Coverage | -2.2x | 3/5 |
| Working Capital | $118M | 2/6 |
| Metric | EVH | Rank |
|---|---|---|
| Operating Cash Flow | $54M | 2/5 |
| Metric | EVH | Rank |
|---|---|---|
| Receivables Turnover | 4.7x | – |
| Fixed Assets Turnover | 25.6x | – |
| Days Sales Outstanding | 78 days | – |
| Payables Period | 8 days | – |
| Metric | EVH | Rank |
|---|---|---|
| Total Revenue | $2.10B | – |
| Operating Income | -$428M | 5/5 |
| SG&A Expense | $292M | – |
| Cost of Goods Sold | $1.74B | – |
| Metric | EVH | Rank |
|---|---|---|
| Shares Outstanding | 113M | – |
| Total Current Assets | $611M | 33.6% of assets |
| Cash & Short-term Investments | $116M | 6.4% of assets |
| Accounts Receivable | $449M | 24.7% of assets |
| Total Liabilities | $958M | 52.7% of assets |
| Short-term Debt | $454M | 25.0% of assets |
Companies classified under the same SEC industry code as Evolent Health, Inc. (Services-Management Services): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWelcome to the Evolent Earnings Conference Call for the Third Quarter ended September 30, 2025. As a reminder, this conference call is being recorded. Your host for the call today from Evolent are ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Evolent Health (EVH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.02 per share a year ago. These figures ...
On Oct. 16, 2026, EVH is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5184 stocks scored that day.
For EVH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Evolent Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
6 issuers in our coverage, EVH included, share the SEC industry code Services-Management Services. The largest are: Bryn Inc. (BRRN), Gartner Inc (IT), Rentokil Initial Plc /Fi (RTO), Franklin Covey Co (FC), Sky Century Investment, Inc. (SKYI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.